Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrin

Overview of attention for article published in Frontiers in Neuroscience, September 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter: 14 X users

Readers on

mendeley: 5 Mendeley

Summary X

So far, Altmetric has seen 14 X posts from 14 X users, with an upper bound of 87,896 followers.

Open Access UCL Research: Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrin https://t.co/Ol1OurKbFc

12 Oct 2023

Reply Repost Favourite

IoN UCL PubMed: Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrin https://t.co/EvXGpW255r

08 Oct 2023

Reply Repost Favourite

New Research: Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrin: Background The anti-seizure medication vigabatrin (VGB) is effective for controlling seizures, especially infantile spasms.… #Neuroscience https:

29 Sep 2023

Reply Repost Favourite

RT @RCSIPharmBioMol: Exciting work by @isabelleboothmn & team in @FrontiersIn which aims to identify #geneticpredictors for vigabatrin indu…

15 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 10 additional X posts.